In our study, we established a clinical link between p-ERK1/2 expression and poor prognosis in DLBCL, and identified a significant positive correlation between CCR7 and p-ERK1/2 expression in DLBCL tissue samples. This evidence concerns the gene MAPK3 and diffuse large B-cell lymphoma.